drugset / Trial / NCT01683955

Topical Tranexamic Acid and Acute Blood Loss in Total Hip Arthroplasty

NCT01683955

Phase 1 Completed 139 enrolled Henry Ford Health System
RandomizedParallel-groupTriple-blindTreatment

Summary

This study aims to assess postoperative blood loss and transfusion rates in total hip replacement after one-time administration of topical tranexamic acid.

Timeline

Start
2013-01-01
Primary completion
2013-11-03
Completion
2013-11-03

Drugs

EvaluationDrugModalityDoseRoute
Subject Tranexamic Acid Small molecule 2 g Topical